Ignite Creation Date:
2025-12-24 @ 4:16 PM
Ignite Modification Date:
2026-01-01 @ 8:32 AM
Study NCT ID:
NCT05172466
Status:
WITHDRAWN
Last Update Posted:
2022-11-25
First Post:
2021-11-22
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Sensation, Motion, and Quality of Life on Natalizumab and Off Natalizumab
Sponsor:
Icahn School of Medicine at Mount Sinai
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2022-10-31
Start Date Type:
ACTUAL
Primary Completion Date:
2022-11-11
Primary Completion Date Type:
ACTUAL
Completion Date:
2022-11-11
Completion Date Type:
ACTUAL
First Submit Date:
2021-11-22
First Submit QC Date:
None
Study First Post Date:
2021-12-29
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-11-21
Last Update Post Date:
2022-11-25
Last Update Post Date Type:
ACTUAL